FIRST-LINE TREATMENT IN PATIENTS WITH INOPERABLE METASTATIC COLON CANCER

FIRST-LINE TREATMENT IN PATIENTS WITH INOPERABLE METASTATIC COLON CANCER

First-line therapy for metastatic colon cancer is most important for a patient. Its median time to progression constitutes the bulk of the patient’s survival. Clearly, it is necessary to choose the most effective combinations of targeted drugs and chemotherapy regimens. The choice of therapy for pat...

Full description

Bibliographic Details
Main Authors:	M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin
Format:	Article
Language:	Russian
Published:	“ABV-press” Publishing house”, LLC 2015-02-01
Series:	Тазовая хирургия и онкология
Subjects:	metastatic colon cancer targeted drugs
Online Access:	https://ok.abvpress.ru/jour/article/view/83

Similar Items

CHOICE OF TARGETED DRUG FOR SECOND-LINE METASTATIC COLON CANCER CHEMOTHERAPY
by: M. Yu. Fedyanin, et al.
Published: (2015-05-01)

Chemotherapy of metastatic colon cancer
by: M. Yu. Fedyanin, et al.
Published: (2015-02-01)

Choice of anti-angiogenic agents in second-line treatment in patients with metastatic colon cancer: bevacizumab, aflibercept, ramucirumab (a literature review)
by: M Iu Fedyanin
Published: (2015-09-01)

PROMISES FOR TREATING COLON CANCER PATIENTS WITH BRAF GENE MUTATION
by: M. Yu. Fedyanin, et al.
Published: (2015-02-01)

Localization of the primary tumor of the colon: аre there essential differences?
by: M. Yu. Fedyanin, et al.
Published: (2017-12-01)

Efficacy of continuing anti-angiogenic agents in the second-line treatment for metastatic colon cancer depending on the KRAS mutation status: a meta-analysis
by: M. Yu. Fedyanin, et al.
Published: (2018-07-01)

Role of microsatellite instability in colon cancer
by: M. Yu. Fedyanin, et al.
Published: (2015-02-01)

CHEMOTHERAPY IN THE MANAGEMENT OF LOCALIZED AND METASTATIC COLON CANCER: NEW AND YET UNFORGOTTEN APPROACHES
by: N. V. Dobrova, et al.
Published: (2017-11-01)

Effect of cancer drugs in patients with metastatic colorectal cancer in terms of mortality reduction
by: M. Yu. Fedyanin, et al.
Published: (2017-12-01)

Systemic Therapy for Advanced and Metastatic Colon Cancer
by: Jae Jun Park
Published: (2019-04-01)

METASTATIC COLORECTAL TREATMENT COSTS OF USING TARGETED DRUGS IN SECOND AND FURTHER LINES THERAPY
by: N. A. Avxentyev, et al.
Published: (2016-09-01)

Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study
by: Girolamo Ranieri, et al.
Published: (2020-11-01)

Corrigendum: Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study
by: Girolamo Ranieri, et al.
Published: (2021-02-01)

Metastatic Colorectal Cancer. First Line Therapy for Unresectable Disease
by: Jorge Aparicio, et al.
Published: (2020-11-01)

The role of regorafenib in the treatment of metastatic colorectal cancer
by: A A Tryakin
Published: (2016-06-01)

Does asymptomatic primary tumor need to be removed in unresectable metastatic colon cancer?
by: M. Yu. Fedyanin, et al.
Published: (2015-10-01)

Metastatic Small Bowel Tumor from Descending Colon Cancer with Extensive Hematogenous or Lymphogenous Spread: Survey of the Japanese Literature
by: Yutaka Kojima, et al.
Published: (2010-09-01)

Circulating miR-618 Has Prognostic Significance in Patients with Metastatic Colon Cancer
by: Maria Radanova, et al.
Published: (2021-03-01)

Second-line targeted therapy for metastatic colorectal cancer. Possibilities for choices
by: L. V. Bolotina, et al.
Published: (2018-11-01)

Multiple Subcutaneous Nodules Leading to Diagnosis of Colon Cancer
by: Irappa Madabhavi, et al.
Published: (2018-07-01)

USE OF A COMBINATION OF АVASTIN AND LOW-DOSE INTERFERON- α IN THE FIRST-LINE TREATMENT OF METASTATIC RENAL-CELL CANCER
by: A. S. Kalpinsky, et al.
Published: (2014-07-01)

USE OF A COMBINATION OF АVASTIN AND LOW-DOSE INTERFERON- α IN THE FIRST-LINE TREATMENT OF METASTATIC RENAL-CELL CANCER
by: A. S. Kalpinsky, et al.
Published: (2014-07-01)

Metastatic colonic and gastric polyps from breast cancer resembling hyperplastic polyps
by: Yoshiya Horimoto, et al.
Published: (2018-03-01)

The Role of Colorectal Cancer Stem Cells in Metastatic Disease and Therapeutic Response
by: Melissa H. Wong, et al.
Published: (2011-01-01)

Сonfirmatory study of the efficacy and tolerability of trifluridine/tipiracil (TAS-102) therapy in the Russian population with chemorefractory metastatic colorectal cancer
by: M. Yu. Fedyanin, et al.
Published: (2020-12-01)

A laparoscopic resection of lung cancer metastatic to transverse colon: A case report and review of the literature
by: Ryota Koyama, et al.
Published: (2019-09-01)

Subsequent anti-VEGF therapy after first-line anti-EGFR therapy improved overall survival of patients with metastatic colorectal cancer
by: Qiu TZ, et al.
Published: (2018-01-01)

Therapeutic effects of pazopanib treatment in patients with metastatic kidney cancer in real clinical practice
by: P. G. Berezin, et al.
Published: (2019-01-01)

Cetuximab in first line treatment of metastatic colorectal cancer
by: Carlo Barone, et al.
Published: (2012-07-01)

Durable complete response in a patient with metastatic left‐sided colon cancer treated with 5‐fluorouracil, folinic acid, and irinotecan (FOLFIRI) and panitumumab: A case report
by: Esther Kim, et al.
Published: (2019-07-01)

The Outcome Of Antracycline-Based Combination Chemotherapy In Metastatic Breast Cancer As A First-Line Treatment
by: Ahmet Dirier, et al.
Published: (2003-03-01)

Targeted Treatment of Colon Cancer with Aptamer-Guided Albumin Nanoparticles Loaded with Docetaxel
by: Yu Z, et al.
Published: (2020-09-01)

Efferent therapy in the first-line drug treatment of metastatic colorectal cancer
by: Z. S. Kotova, et al.
Published: (2018-07-01)

Molecular biomarkers and histological parameters impact on survival and response to first- line systemic therapy of metastatic colorectal cancer patients
by: Rebersek Martina, et al.
Published: (2019-03-01)

Pharmacoeconomic-guided choice of systemic chemotherapy in metastatic colorectal cancer patients
by: M. Yu. Fedyanin, et al.
Published: (2017-09-01)

Metastatic colon cancer of the small intestine diagnosed using genetic analysis: a case report
by: Mikiko Matsuo, et al.
Published: (2020-08-01)

Ameboma of the colon with amebic liver abscess mimicking metastatic colon cancer
by: Fernandes Hilda, et al.
Published: (2009-04-01)

Toxicity and efficacy of biosimilar bevacizumab in the second-line therapy for metastatic colon cancer in routine clinical practice: results of an independent observational study
by: M. Yu. Fedyanin, et al.
Published: (2021-06-01)

Pharmacoeconomic evaluation of the use of targeted therapy and chemotherapy in the first- and second-line therapies for metastatic colorectal cancer
by: A. A. Tryakin, et al.
Published: (2018-11-01)

Pazopanib as first-line therapy for patients with metastatic kidney cancer
by: B. Ya. Alekseev, et al.
Published: (2018-07-01)